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ABSTRACT
In vitro stimulation of human female T cells with male HLA-identical dendritic cells resulted in the generation
of HLA-DQB1*0501/0502-restricted minor histocompatibility H-Y antigen-specific CD4 T cell clones. Two
clones generated from different HLA-identical pairs were analyzed. Use of HLA-DQ5-expressing female
Epstein-Barr virus transformed B lymphoblastoid cell lines transfected with various H-Y genes and loaded with
overlapping peptides demonstrated that both T cell clones are specific for a peptide encoded by DDX3Y.
Previously, an HLA-DQ5-restricted T cell clone specific for the same peptide was isolated from a patient with
graft-versus-host disease. Thus, we compared the T cell receptor (TCR) rearrangements of the 2 in vitro
generated T cell clones and the ex vivo isolated T cell clone. All 3 clones shared the same TCRBV5-4* gene
segment and 2 of 3 clones also used similar TCR-V segments. Our results suggest that T cells recognizing
the HLA-DQ5/DDX3Y T cell epitope might be characterized by a relatively limited TCR- repertoire. The
differences in the junctional TCR- region had no effect on the antigen specificity, but altered the capacity of
the TCR to distinguish the HLA-DQ5/DDX3Y complex from its allelic counterpart. The results also dem-
onstrate that in vitro stimulation of T cells with allogeneic HLA-identical dendritic cells may facilitate the
characterization of in vivo, potentially relevant HLA class II-restricted minor H epitopes.
© 2006 American Society for Blood and Marrow Transplantation
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tNTRODUCTION
Stem cell transplantation (SCT) is a curative
herapy for patients with hematologic malignancies.
owever, in HLA-identical donor/recipient pairs,
raft rejection or graft-versus-host disease (GVHD)
an occur. These complications are due to vigorousoavid Laurin and Eric Spierings contributed equally to this study.
114cell responses directed against minor histocom-
atibility (H) antigens [1,2]. Minor H antigens are
olymorphic peptides derived from endogenously
rocessed cellular proteins and are presented on the
ell surface by major histocompatibility complex
MHC) molecules [3,4]. These proteins are encoded
y multiallelic, mostly biallelic, autosomal genes
hat are transmitted with Mendelian segregation [5]
r by the various genes on the Y chromosome
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Isolation of HLA DQ5-DDX3Y-Specific T Cell Clones In Vitro and In Vivo 11156-16]. H-Y-speciﬁc immune responses can occur
ecause signiﬁcant disparity at the amino acid res-
dues between each H-Y gene and its X homolog
an lead to peptide recognition by female T cells,
hereas male T cells develop tolerance to these
self-antigens.”
In humans, a number of minor H antigens has
een characterized (reviewed by Spierings et al [17]).
lthough a much larger number of unidentiﬁed minor
antigens may exist, it is unlikely that each individual
ismatched minor H antigen is clinically relevant,
ecause not all patients develop GVHD after HLA-
atched SCT. Population studies and in vitro analy-
es have suggested that the HLA class I-restricted
A-1 and SMCY are more immunogenic than others
1,18,19]. In the case of HA-1, restricted T cell recep-
or (TCR) V usage was suggested to be a possible
olecular basis for immunodominance [20,21].
The majority of the currently identiﬁed minor H
ntigens is restricted to HLA class I. However, the
ore frequent identiﬁcation of MHC class I- rather
han MHC class II-associated peptides is unlikely to
e related to a more important role for CD8 T cells
n the induction of GVHD. Initiation of GVHD has
een shown to require the participation of CD4 T
ells that help CD8 cytotoxic T cells directly
hrough cytokine secretion or indirectly through ac-
ivation of dendritic cells (DCs) [13,22-25]. Impor-
antly, CD4 HLA class II-restricted H-Y-speciﬁc
elper T cells that support the proliferation of CD8
cells have been isolated from a female patient who
ejected a male HLA-identical stem cell transplant
13]. Moreover, involvement of CD4 T cells is sup-
orted by mice experiments that have demonstrated
ejection of syngeneic male skin grafts by T helper
ells without requirement for CD8 cytotoxic T lym-
hocytes [25]. In addition, the presence of CD4 T
ells with antirecipient speciﬁcity, rather than CD8
cells, has been shown to correlate with GVHD [22].
urther, H-Y has been shown to elicit sustained
D4 helper T and B cell responses [6,15,26,27].
We previously reported the in vitro generation of
-Y-speciﬁc, HLA-DQ5-restricted T cell clones us-
ng HLA-identical allogeneic DCs as antigen-present-
ng cells [28]. In the present study, using the same
ethod, we report the generation of another CD4 T
ell clone obtained from a different HLA-identical
ibling pair, which also recognizes HLA-DQ5/H-Y.
ecently, an HLA class II-associated minor H-Y pep-
ide has been identiﬁed by using T cells developed in
ivo in a male patient with chronic myeloid leukemia
ho developed acute GVHD grade III-IV after trans-
lantation with HLA genotypically identical female
tem cells. A clone, named JBB4 (Clone Type I in
aber et al [29]), was derived by limiting dilution from
his patient’s peripheral blood mononuclear cells
PBMCs) that were harvested at day 83 after trans- 1lantation during severe GVHD [30]. The peptide
ecognized by this clone is derived from the DDX3Y
ene and its recognition is restricted by HLA-DQ5.
he goal of this study was to identify HLA class
I-associated minor H antigens, compare the epitopes
ecognized by in vitro generated T cell clones with
hose isolated after SCT, and analyze their TCR-
earrangements.
ETHODS
edium and Reagents
RPMI-1640 medium (Life Technologies, Eggen-
tein, Germany) was supplemented with l-glutamine
2 mM), penicillin (100 IU/mL), streptomycin (100
g/mL), NaHCO3 (1.5 mg/mL), and 10% pooled,
eat-inactivated human AB serum. Recombinant hu-
an (rh) granulocyte-macrophage colony-stimulating
actor, recombinant human interleukin (IL)-2, rhIL-4,
nd recombinant human tumor necrosis factor  were
urchased from R&D Systems (Abington, United
ingdom). HLA typing was assessed by serology and
horoughly characterized by oligonucleotide typing.
nti-HLA class I (W632), anti-HLA-DR (L243), and
nti-HLA-DP (B7-21) were kindly provided by
. Chopin (Hospital Cochin, ICGM, Paris, France),
nd anti-HLA-DQ (SPVL3) was purchased from Im-
unotech (Marseille, France).
eneration of Minor H Antigen-Specific T Cell
ines and Clones
We stimulated 1  105 PBMCs from a female
onor with 1  104 30-Gy irradiated DCs generated
rom her HLA-identical brother in a ﬁnal volume of
00 L in 96-well round-bottom plates. After 5 days
f culture, nonadherent cells were transferred to a new
ulture plate. Three rounds of stimulation were car-
ied out in 24-well plates every 10 days. In addition,
 105 T cells were stimulated with 1  106 30-Gy
rradiated HLA-identical PBMCs. Cultures were sup-
lemented with 5 U/mL rhIL-2. Cells were subse-
uently tested for their speciﬁcity in proliferation and
ysis assays. CD4 T cells were further selected by
epleting CD8 T cells with anti-CD8 antibody-con-
ugated with magnetic beads (Dynal SA, Oslo, Nor-
ay). Graded numbers of T cells (1 104 to 0.6 103
ells/well) were then cultured in 96-well round-bot-
om plates with 1  104 irradiated PBMCs from the
LA-identical brother in the presence of 5 U/mL
hIL-2. At day 10, wells were split and tested for
roliferation against 50-Gy irradiated Epstein-Barr
irus transformed B (EBV-B) lymphoblastoid cell
ines (LCLs) derived from the female donor, the
LA-identical brother, or HLA-mismatched individ-
als. Positive wells were selected and expanded by
0-day stimulations of 1  105 T cells with 3  105
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D. Laurin et al.1116LA-identical 50-Gy irradiated EBV-B LCLs in the
resence of 5 U/mL rhIL-2.
Clones were derived from these lines, as previ-
usly described [28]. Brieﬂy, speciﬁc T cells were
loned by limiting dilution at cell concentrations of
, 1, or 0.4 cells/well, in 96-well round-bottom
icrotiter plates, in the presence of 2.5  105/mL
rradiated (30-Gy) PBMCs plus 0.5  105/mL irra-
iated (50-Gy) EBV-B LCLs derived from the
llogeneic HLA-identical donor and 10 U/mL
hIL-2. The generated T cell clones were expanded
n the presence of 0.5  105 EBV-B LCL and
hIL-2. The phenotype of the generated clones was
nalyzed on a FACScan using phycoerythrin/ﬂuo-
escein isothiocyanate-labeled (CD4 and CD8) an-
ibodies (BD Biosciences, Le Pont de Claix,
rance).
ixed Leukocyte Reaction Assays
T cell clones, 1  104 CD4, were incubated in
riplicate with 3 104 50-Gy irradiated EBV-B LCLs
n a ﬁnal volume of 200 L in 96-well round-bottom
lates. After 3 days of culture, 1 Ci/well 3H-[methyl-
hymidine] was added for the last 16-18 hours. Cells
ere collected with a Filtermate 196 multiple har-
ester (Packard Inc, Prospect, Ct) and thymidine in-
orporation was measured in a TopCount liquid scin-
illation counter (Packard Inc).
C Culture
Monocyte-derived DCs were prepared as previ-
usly described [31-33]. Brieﬂy, monocytes isolated
rom peripheral blood were cultured in plastic wells
ith 200 U/mL recombinant human granulocyte-
acrophage colony-stimulating factor and 500 U/mL
hIL-4 for 6 days in the presence of 10% human
erum. On days 2 and 5, cultures were fed by remov-
ng 3 mL medium and adding 3 mL fresh medium
ith cytokines. DC maturation was obtained by re-
oving immature DCs and plating them in Teﬂon
ells in the presence of 200 IU/mL recombinant hu-
an tumor necrosis factor . DC differentiation and
iability were checked by cytoﬂuorimetric analyses
nd functional assays.
everse Transcriptase Polymerase Chain Reaction
mplification and Sequencing Protocols
Total RNA from clones E6 and L14 was isolated
rom 1  106 cells using the Rnagent Kit (Promega,
adison, Wis). Total RNA was converted into ﬁrst-
trand cDNA using an oligo(dT) primer (Amersham
harmacia Biotech, Orsay, France) and avian myelo-
lastosis virus reverse transcriptase (RT) according to
he manufacturer’s speciﬁcations (Promega).
Polymerase chain reaction (PCR) ampliﬁcation
30 cycles) was carried out using 25 V-region se- ouence-speciﬁc 5= sense primers for TCR-V families
nd a 3= antisense C primer as previously described
34]. As a positive internal control, 5= sense and 3=
ntisense C-region primers were included. Cycles
onsisted of 95°C denaturation, 57°C primer anneal-
ng, and 72°C extension steps for 1 minute each. PCR
as carried out in a Biomed Thermocycler 60
Biomed Instruments, Fullerton, Calif) using 2.5 U
aq DNA polymerase (Cetus, Emeryville, Calif) in a
olution containing 4 pmol/L of primers, 0.5 mM
ach of dNTP; 50 mM KCl; 10 mM Tris-HCl (pH
.4); 4 mM MgCl; and 5 g of sample. PCR products
ere sequenced by Genoscreen (Lille, France). The
btained TCR sequences were analyzed with an In-
ernet IMGT database (http//:imgt.cines.fr:8104).
TCR sequence analysis of clone JBB4 has been
escribed previously [35]. TCR- PCR ampliﬁcation
as performed as described by Moonka and Loh [36].
rieﬂy, degenerated primers were designed to take
dvantage of a highly conserved sequence of the
CR- variable region. The consensus primer con-
ains an additional anchor sequence (ANB) at the 5=
nd that is used during the ampliﬁcation as described.
he constant region primers (CA) are antisense in
rientation. The CA1 primer was used for the initial
CR and the CA2 was used for a second, semi-nested
CR. Second PCR ampliﬁcation products were
loned in pGEM-T Easy Vector (Promega) and se-
uensed using the CA2 primer. The complete se-
uence of the degenerated primer was CGACTC
AGTCGACATCGATC(T,A)C(T,A)C(T,A)C(T,
,G)TGGTAC(T)C(A,G)T(A,G)C(T,A,G)C(T,A)A;
hat of the ANB primer was CGACTCGAGTCGA-
ATCGAT; that of the CA1 primer was CTGT-
ATATACACATCAGAATCC; and that of the CA2
rimer was AATAGGCAGACAGACTTGTCACT.
he obtained TCR sequences were analyzed using the
nternet IMGT database.
nzyme-Linked Immunosorbent Assays
We stimulated 1.5  105/mL CD4 T cell clones
ith 5  105/mL 50-Gy irradiated EBV-B LCLs in
-VIVO 20 medium (Cambrex, Emerainville, France)
ithout serum. Supernatant was removed after 24
ours. Cytokine concentrations were evaluated by
tandard, commercially available enzyme-linked im-
unosorbent assays according to the manufacturers’
nstructions (IL-4, IL-10, and interferon  from Bio-
ource, Nivells, Belgium; and transforming growth
actor  from R&D Systems).
Cell Epitope Characterization
Four Y-chromosome-encoded genes (DDX3Y,
IF1AY, RPS4Y, and TMSB4Y) were retrovirally trans-
uced into female HLA-DQ5 EBV-B LCLs as previ-
usly described [30]. H-Y-speciﬁc CD4 T cell clones
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Isolation of HLA DQ5-DDX3Y-Specific T Cell Clones In Vitro and In Vivo 1117ere stimulated with each of the H-Y-transduced
BV-B LCLs. Proliferation was measured by 3H-
methyl-thymidine] incorporation at day 2. For map-
ing of the exact MHC class II-restricted T cell epitope,
e synthesized overlapping 20-mer peptides that are
ncoded in the regions of DDX3Y that differ from DBX
nd a truncated peptide from the positive 20-mer pep-
ide. These peptides were tested with the CD4 T cell
lones at a concentration of 0.1 g/L, with autologous
ecipient EBV-B LCLs as antigen-presenting cells.
ESULTS
n Vitro Generation and Specificity Analysis of
inor H Antigen-Specific CD4 T Cell Clones
In a previous study [28], we generated in vitro an
-Y-speciﬁc HLA-DQB1*0501/0502-restricted CD4
cell clone, designated as L14, from a healthy blood
onor HLA-identical sibling pair whose HLA typing
as HLA-A*2601/0201, -B*3901/4001, -C*1203/0304,
DRB1* 1601/0101, -DQB1*0501/0502, DPB1*0301/
401. Using the same methodology (see Methods), a
econd set of T cell lines was established from another
LA-identical sibling donor/recipient pair whose HLA-
yping was HLA-A*0201, -B*4901/3501, -Cw*0701/
401, -DRB1*0101, DQB1* 0501, -DPB1* 0401/0402.
he subsequent speciﬁcity analysis of the latter T cell
ines revealed speciﬁc recognition of male but not of
emale stimulator cells expressing the restriction mole-
ule HLA-DQB1*0501 or HLA-DQB1*0502. The re-
ponse was signiﬁcantly blocked by HLA-DQ-speciﬁc
onoclonal antibodies. After limiting dilution, some T
ell clones were found to be male speciﬁc and HLA-
QB1*0501/0502 restricted (Table 1). One clone, des-
gnated as E6, was selected for detailed analysis in par-
llel with L14, the previously isolated H-Y-speciﬁc
able 1. Patterns of Speciﬁcity and Restriction of Responder T Cells Issu
Clone F5
*
DQ*0501 female sibling 296  35
DQ*0501 male sibling 3608  70
DQ*0501 male 356  90
DQ*0501 female 1062  97
DQ*0602 male 511  98
†
No monoclonal antibody 3608  70
Anti-class I 3020  87
Anti-DR 11 092  285
Anti-DP 2548  194
Anti-DQ 538  120
D indicates not done.
T cell clones from sibling B (male) were tested for their ability to pro
from sibling A (female) or from unrelated blood donors express
T cells from sibling B were tested in Mixed leukocyte reaction assa
sibling A in the presence or absence of anti-HLA monoclonal an
was measured at day 3. Clone L14 is shown as a positive control of spLA-DQB1*0501/0502-restricted CD4 T cell clone
28]. CD4 T cell clones E6 and L14 were stimulated
ith different HLA-DQ5-expressing male antigen-pre-
enting cells (Figure 1). Both clones proliferated
n response to male HLA-DQB1*0501 or HLA-
QB1*0502 antigen-presenting cells but not to HLA-
QB1*0503- or HLA-DQB1*0504-expressing male
BV-B LCLs.
haracterization of the
LA-DQB1*0501/0502-Restricted H-Y-Specific
Cell Epitope
Several H-Y genes transduced into HLA-DQ5 fe-
ale EBV-B LCLs were used in proliferative assays
Figure 2). Clones E6 and L14 proliferated against the
DX3Y gene-transduced EBV-B LCL but not against
BV-B LCL transduced with other H-Y genes. Autol-
gous female EBV-B LCLs were loaded with mixtures
f overlapping 20-mer DDX3Y peptides. Clones L14
nd E6 proliferated against a mixture containing the
ivergent amino acid sequences compared with DBX
14 to 431, ie, Mix2 (Figure 3A,C). Because both clones
roliferated against the same overlapping mixture of
DX3Y peptides, the individual peptides present in this
ixture were further used to stimulate clones L14 and
6. Both clones recognized the peptide with the se-
uence TGSNCPPHIENFSDIDMGEI (Figure 3B,D).
his 20-mer peptide contained the peptide recog-
ized by HLA-DQ5-restricted H-Y-speciﬁc Cyto-
oxic T lymphocyte (CTL) isolated and ex vivo ex-
anded from a patient with GVHD, whose HLA
yping was HLA-A*01/02, -B*07/60(40), -Cw*03/07,
DRB1*0101/1501(2), -DRB5*01, -DQB1*0501/06,
DPB1*0401 [30]. Likewise, the 12-mer peptide re-
orted to be the minimal peptide recognized by the ex
ivo expanded clones was recognized by the clones L14
Sibling B
H9 E6 L14
 108 676  85 329  86
 421 9887  1024 22 939  739
 430 12 329  386 ND
 35 517  50 ND
 20 1328  54 2267  341
 421 76 060  9098 22 939  739
 43 ND 22 755  3757
 334 39 030  1963 26 154  915
 83 57 745  5206 24 002  2908
 183 5903  557 484  68
e against Epstein-Barr virus type B lymphoblastoid cell lines derived
t expressing HLA-DQ0501.
st Epstein-Barr virus transformed B lymphoblastoid cell lines from
s directed against class I DR, DP, or DQ molecules. 3H-thymidineed from
527
8052
4563
1210
448
8052
6412
7774
6966
928
liferat
ing/no
ys again
tibodieeciﬁcity and restriction toward HLA-DQ0501/HY epitope.
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D. Laurin et al.1118nd E6 (Figure 4). Thus, the DDX3Y peptide recog-
ized by the 2 CD4 T cell clones generated in vitro
fter stimulation with DCs is identical to the DDX3Y
eptide recognized by the ex vivo isolated T cell clone.
CR- Rearrangements of the 3
LA-DQ5-Restricted H-Y-Specific CD4
Cell Clones
Although we cannot exclude the possibility that
ther epitopes were also targeted by other clones,
he 20-mer DDX3Y epitope recognized by clones
14, E6, and JBB4 was likely to be a strong epitope.
ecause in many instances immunodominant pep-
ides have been reported to select highly restricted
CR repertoires, we hypothesized that this phe-
omenon may be of importance for DQ5/H-Y. To
ddress this question, we ampliﬁed the TCR rear-
angements from the 3 clones by RT-PCR. For
CR-, sequence analysis showed the usage of the
ame TCRBV5-4* by in vitro generated and the ex
ivo expanded CD4 T cell clones. With regard to
he N-D-N regions and the TCRBJ usage, both in
itro generated clones have rearranged a TCRBD2
igure 1. Reactivity of H-Y minor H antigen-speciﬁc T cell clo
QB1*0503- or HLA-DQB1*0504-expressing male EBV-B LCL
xpressing male EBV-B LCLs. Proliferation was measured by thymo a TCRBJ2-5*01 gene segment, whereas the ex sivo expanded clone has a rearranged TRBD1 to a
RBJ2-7*01 gene segment, which shares strong
imilarities with TCRBJ2-5*01 in the encoded
mino acid sequences (Table 2). Thus, these data
uggest that this particular H-Y epitope might se-
ect a relatively skewed TCR- repertoire.
However, because the junctional regions of the 3
CR- chains were not identical, one could argue
hat antigen recognition rely mostly on the TCR-
hain. In that case, expression of similar TCR-
hains by the 3 clones, together with recognition re-
uirements for the HLA-DQ5/H-Y complex, could
e at the origin of the skewing of the TCR- reper-
oire toward the exclusive usage of the TCRBV5-4*.
s shown in Table 2, 2 of the 3 clones, ie, JBB4 and
6, have rearranged the same TCR-V segment
TCRAV8-3) to different TCR-J gene segments,
hereas clone L14, which used the same combinatory
CR- rearrangement (V-D-J) as clone E6, showed a
uite distinct TCR- rearrangement. Therefore,
hese results suggest that the TCR- chain of these 3
lones, which recognize a single DDX3Y peptide in
he context of HLA-DQ5, is not likely to be respon-
ward HLA-DQB1*0501- and HLA-DQB1*0502- but not HLA-
es E6 (A) and L14 (B) were stimulated with various HLA-DQ5-
incorporation, as described in Methods.nes to
s. Clonible for the common TCRBV5-4* usage.
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Isolation of HLA DQ5-DDX3Y-Specific T Cell Clones In Vitro and In Vivo 1119nly the P9 Residue of HIENFSDIDMGE
s Critical for Epitope Recognition by L14
nd E6 Clones
Because the analysis of the TCR rearrangements
f the 3 T cell clones demonstrated similar V but
ifferent TCR- junctional and TCR- regions, we
nvestigated whether the 3 disparate amino acids that
iffer from the DDX3X sequence (P4, P8, and P9)
ere equally important for DDX3Y recognition by
he 3 clones. It has been reported that P4 and P9
mino acid residues are critical for DDX3Y recogni-
ion by JBB4 [30]. However, as shown in Figure 5, the
roliferative responses of L14 and E6 clones were
ritically dependent only on residue P9. Substitution
f P4 or P8 did not impair T cell proliferation of these
in vitro generated T cell clones, whereas , as ex-
ected, substitution of the 3 amino acid residues, P4,
8, and P9, resulted in the absence of response.
ISCUSSION
Identiﬁcation of minor H antigens and studies on
igure 2. Proliferation of clones E6 and L14 in response to DBY-e
ith RPS4Y, TMSB4Y, EIF1AY, or DDX3Y genes were used to stim
ere used as positive controls. Proliferation was measured by thymhe role of minor H antigen-speciﬁc T cell subsets in bVHD and host-versus-graft reactions are dependent
n the availability of speciﬁc T cell clones. Therefore,
n vitro generation of MHC class I-restricted CD8 T
ells speciﬁc for minor H antigens is feasible and
elevant [37,38]. We previously demonstrated the fea-
ibility of generating HLA class II-restricted CD4 T
ell clones against as yet unidentiﬁed minor H anti-
ens from healthy blood donors [28]. Here we report
n comparative studies between in vitro generated and
x vivo expanded male speciﬁc MHC class II-re-
tricted T cells in terms of their T cell epitope spec-
ﬁcity, MHC class II restriction molecule, and TCR
earrangements. Two CD4 T cell clones generated
n vitro were derived from 2 independent HLA-iden-
ical sibling pairs. Both T cell clones exclusively rec-
gnized a male-speciﬁc minor H antigen in the con-
ext of HLA-DQB1*0501/0502. The subsequent
hemical identiﬁcation of the H-Y T cell epitopes
ecognized by the 2 in vitro generated CD4 T cell
lones revealed a single DDX3Y epitope. We previ-
usly showed in detailed analyses that the X-homolog
eptide derived from the DDX3X protein could not
epitopes. HLA-DQ5-expressing female EBV-B LCLs transduced
clone E6 (A) or clone L14 (B). HLA-identical male EBV-B LCLs
ncorporation, as described in Methods.ncoded
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D. Laurin et al.1120hocyte [30]. This epitope was previously reported
o be recognized by T cells isolated ex vivo from a
atient with grade III-IV GVHD [29,30]. Thus, al-
hough we cannot exclude the possibility that other
pitopes were also the targets of other clones, the
dentiﬁcation of a single epitope targeted by 3 clones
enerated from 3 different donors, using in vitro or ex
ivo methodologies, suggests that HLA-DQ5/
DX3Y is likely to be a strong epitope. The strong
mmunogenicity of the DQ5/DDX3Y epitope is fur-
her supported by the fact that attempts to generate
RB1*1501/DDX3Y-speciﬁc T cell clones after
ex-mismatched transplantation failed. Since a
RB1*1501/DDX3Y -speciﬁc T cell clone was iso-
ated by Zorn et al [15] from a patient with chronic
VHD, detailed studies in recipient/donor pairs with
ifferent disease statuses and GVHD backgrounds
nd displaying 1 or both of these 2 HLA-alleles are
equired to further elucidate the relative immu-
odominance of these 2 minor H antigens. Inter-
stingly, the proﬁle of secretion of the 2 in vitro
enerated DQ5/DDX3Y-speciﬁc T cell clones was
igure 3. Proliferation of clones E6 and L14 in response to partic
egion of DDX3Y were loaded onto autologous EBV-B LCLs. Mi
BY, Mix2 contains 11 peptides from regions 114-431, and Mix3
lso used individually (ppt 171-190 sequence is TGSNCPPHIEN
ontrols. Clone E6 (A, B) and clone L14 (C, D) proliferation wasimilar and showed a Th0 proﬁle (not shown). The wx vivo isolated clone JBB4 also showed a Th0
roﬁle, but with predominant IL-4 and interferon 
ecretion [34].
Previous studies on T cell recognition of the
HC class I-restricted HA-1 antigen demonstrated
he exclusive usage of TCRVB7-9*03 [21]. Also in
urine studies, minor H antigen-speciﬁc CD4
cells displayed limited TCR-V usage in 2 different
ice strains [39]. These observations prompted us to
nalyze the TCR-V usage of the 3 different MHC
lass II-restricted T cell clones. The same TCR-V
ombinatory rearrangement was used by the 2 in vitro
enerated T cell clones, ie, TCRBV5-4*, TCRBD2,
nd TCRBJ2-5*01 (Table 2). The ex vivo isolated
cell clone JBB4 also used TCRBV5-4*, but with a
istinct N-D-N and TCRBJ gene segment. The di-
ersity in the N-D-N and J regions and usage of an
xclusive TCR-V gene segment is reminiscent of a
revious report showing that 12 different groups of
A-2-speciﬁc T cell clones could be identiﬁed with
egard to their usage of TCR- and - chains in 1
atient [40]. However, in these clones, TCR-V usage
BY-encoded peptides. A, C, Overlapping peptides from divergent
tains 11 peptides, corresponding to amino acids 1-123 of DDX3Y
s 10 peptides from regions 422-630. B, D, Peptides in Mix2 were
MGEI). HLA-identical male EBV-B LCLs were used as positive
ed by thymidine incorporation, as described in Methods.ular D
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Isolation of HLA DQ5-DDX3Y-Specific T Cell Clones In Vitro and In Vivo 1121hereas V usage was diverse but always rearranged to
he same J, thus emphasizing its role in peptide recog-
ition. Here we report that TCRBV but neither
CRAV nor TCRAJ usage is common in 3 T cell clones
enerated from 3 distinct donors recognizing the same
LA class II-associated minor H peptide, suggesting
hat TCRBV might exert DDX3Y speciﬁcity. Accord-
ngly, while investigating the inﬂuence of the 3 disparate
mino acids that differ from the DDX3X sequence (P4,
8, and P9) on T cell recognition, we observed that only
he P9 residue was critical for recognition by L14 and E6
lones, whereas P4 and P9 amino acid residues have
een described as crucial residues for DDX3Y recogni-
ion by JBB4 [30]. Thus, our results demonstrate that the
ifferences in the junctional TCRB region do not affect
he antigen speciﬁcity of the DDX3Y-speciﬁc T cell
lones, but rather alters the capacity of the TCR to
istinguish the HLA-DQ5/DDX3Y complex from its
llelic counterpart.
Thus, in accordance with a previous report that
emonstrated interindividual conservation of the
CR- chain V region by HA-1-speciﬁc T cell clones
21], our data show a limited TCRBV usage of T cells
peciﬁc for an HLA class II-associated minor H-Y
eptide.
HLA-DQ5 is expressed at frequencies of almost
igure 4. Proliferation of clones E6 and L14 in response to the
reviously identiﬁed minimal peptide for maximal recognition. The
0-amino acid long peptide TGSNCPPHIENFSDIDMGEI (171-
90) and the 12-amino acid short peptide HIENFSDIDMGE were
oaded onto autologous female EBV-B LCLs; HLA-identical male
BV-B LCLs were used as positive controls. Proliferation of clones
6 (A) and L14 (B) was measured by thymidine incorporation, as
escribed in Methods.9% in the white population and 45% in black ethnic Ta Ex TC
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D. Laurin et al.1122roups. Expression of HLA-DQB1*0503 or HLA-
QB1*0504 in these populations is rare [41], whereas
LA-DQB1*0501 and HLA-DQB1*0502 are the
ost frequent alleles. This suggests that the HLA-
Q5/DDX3Y peptide could be frequently involved in
he induction of GVHD and host-versus-graft reac-
ions after sex-mismatched SCT.
In our study, 2 CD4 T helper clones generated
rom distinct sibling pairs were produced in vitro after
timulation with HLA-identical DCs of male origin.
n both cases, the responding T cells were harvested
rom females who had been pregnant. The risk of
VHD has been shown to be higher when male
ecipients receive transplants from female donors who
ave undergone multiple pregnancies [42,43]. More-
ver, low levels of primed H-Y-speciﬁc tetramer pos-
tive CD8 T cells can be detected in the peripheral
lood of multiparous female mice [44]. Similarly, in
umans, minor H antigen-speciﬁc T cells speciﬁc for
-Y and for the autosomally encoded minor H anti-
ens HA-1 and HA-2 can be isolated from the periph-
ral blood of multiparous females [45]. It is thus pos-
ible that our ability to induce T cell activation against
he male antigen in vitro is due to pre-existing T cells.
nalyses of the immune status with regard to DQ5/HY
sing ELISPOT assays have been planned.
In conclusion, we report on the recognition of the
LA-DQ5/DDX3Y epitope by 3 independently gen-
rated CD4 T cell clones that were isolated in vitro
rom healthy blood donor pairs using allogeneic DCs
s primary stimulators or expanded ex vivo from a
atient with GVHD. These 3 clones used similar
CR-Vs for the recognition of this epitope, which
trongly suggests that HLA-DQ5/DDX3Y may be a
trong epitope. Moreover, the present data demon-
trate that in vitro stimulation of T cells with alloge-
igure 5. Only the P9 residue of HIENFSDIDMGE is critical for
emale EBV-B LCLs were primed for 1.30 hours with the indicated
ontrol. Then the L14 and E6 clones were added to wells at a ratio
or 16 hours and proliferation was measured as indicated in Methoeic HLA-identical dendritic cells may facilitate theharacterization of in vivo potential relevant HLA
lass II-restricted minor H epitopes.
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